Xarelto Manufacturers Continue to Pursue FDA Approval Even as Lawsuits Rise
It was recently announced that Bayer and Johnson & Johnson, the manufacturers of Xarelto, will continue to pursue additional FDA approvals for the drug, only this time, for stroke patients. Even as the two manufacturers continue to be hit with lawsuits by consumers who have been injured by the drug, they continue to pursue permission to market the drug for off-label use.
Considering that there are currently hundreds of lawsuits being filed against Xarelto, it would seem like an rash decision by Bayer and Johnson & Johnson to continue to pursue FDA approvals. In December and January, the lawsuits that have been filed against the two manufacturers were consolidated into multidistrict litigation in two U.S. courts, as well as into a mass tort program.
As the lawsuits regarding Xarelto continue to rise, it’s important that consumers be aware of the potential deadly side effects that consumption of the pharmaceutical drug can have. In many cases, patients have been prescribed the blood thinner after knee or hip surgery. Unfortunately, because Xarelto does not yet have an antidote, patients may experience internal bleeding. Thousands of people have thus far been injured by the drug and the number of lawsuits has similarly risen in the past few months.
Xarelto attorneys within our firm are studying, examining and investigating current Xarelto claims on behalf of people or families injured by the drug. Some of the side effects include hemorrhaging, internal bleeding, stroke and or death. If you or a loved one has experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at 1.866.705.7584 or by email at email@example.com.
About the Author
Majed Nachawati is a dedicated Xarelto Lawyer with a focus on representing victims and families harmed by this dangerous drug on a nationwide basis. Mr. Nachawati has resolved numerous dangerous drug medication cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past six consecutive years for legal excellence, in connection with noteworthy settlements for pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at firstname.lastname@example.org or by calling 1.866.705.7584.